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The proto-oncogene c-ets is exceptional in two respects.
First, its viral counterpart is part of the genome of an
unusual acute avian leukaemia virus, E26, that contains a
tripartite transforming gene consisting of the viral gag gene
linked to v-myb and v-ets sequences (Leprince et al., 1983;
Nunn et al., 1983). Second, in the human (but not the
chicken), v-ets is homologous to sequences in two noncon-
tiguous regions, one (c-ets-1) on chromosome 11, the other
(c-ets-2) on chromosome 21 (de Taisne et al., 1984; Watson
et al., 1985). There is no homology between the two c-ets
sequences except for a small overlap that encodes 14 amino
acids, 12 of which are conserved between the two loci; both
loci are transcribed in human cells (Watson et al., 1985).
There is no direct evidence implicating the c-ets sequences in
human neoplasia, though the c-ets-1 gene has been localized
to chromosome 1l(q23-24) (de Taisne et al., 1984), a region
in which a constitutive fragile site has been found (Yunis &
Soreng, 1984). There is, however, circumstantial evidence
linking rearrangement of the c-ets domains with some
human myeloid leukaemias and a lymphoma. First, Diaz et al.
(1986) hybridized a v-ets probe to metaphase chromosomes
from three patients with acute monocytic leukaemia, each of
whom had a t(9; 11)(p22;q23), and demonstrated trans-
location of the c-ets-1 gene to the short arm of chromosome
9. However, no restriction fragment length polymorphisms
of the c-ets-I gene could be found in leukocyte DNA from
these patients. Second, analyses of panels of somatic cell
hybrids derived from a human myeloid/lymphoid leukaemic
cell line carrying the (4;11)(q21;q23) translocation showed
that the c-ets-1 domain had been translocated from chromo-
some 11 to chromosome 4; similarly, translocation of c-ets-2
from chromosome 21 to chromosome 8 was found in acute
nonlymphoblastic leukaemia (ANLL) cells (FAB class M2)
with a t(8;21)(q22;q22) (Sacchi et al., 1986). Again, however,
Southern blot analyses failed to demonstrate rearrangement
of c-ets sequences in DNAs from leukocytes of ANLL
patients with either the (4; 11) or (8;21) translocation. Third,
rearrangement and amplification of c-ets-I sequences have
been found in DNA from one ANLL (FAB class M4) in
which there was a homogeneously staining region at llq23,
and in DNA from a small lymphocytic cell lymphoma with
an inversion at llq23 (Rovigatti et al., 1986). Unspecified
alterations in the c-ets-l locus in several other ANLLs with
karyotypic abnormalities involving band 1lq23 have also
been reported by Rovigatti et al. (1986).
A t(4; 1 1)(q21;q23) is also associated with a sub-group of
acute lymphoblastic leukaemias (ALL) (Arthur et al., 1982;
Rowley & Testa, 1982; Mirro et al., 1986). We have
examined the DNAs from peripheral blood leukocytes from
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7 ALLs for evidence of re-arranged c-ets-I sequences.
Hybridization of a c-ets-1 probe (de Taisne et al., 1984) to
Southern blots of electrophoretically fractionated Eco RI-
digested normal peripheral blood leukocyte DNA (Figure 1)
revealed the 8.6kbp fragment homologous to c-ets-1
described previously (de Taisne et al., 1984). The same
8.6kbp fragment was found in the DNAs from all 7 ALLs,
and two of them also showed extra c-ets-1-homologous
fragments (Figure 1): one (ALL/01; lane a) at 4.1 kbp, the
other (ALL/04; lane d) at 5.8kbp (lane d was overloaded,
and the 25 kbp band in ALL/04 is due to a partial digest
fragment).
It is formally possible that we have detected amplified
c-ets-related sequences in ALL/01 and ALL/04, in a manner
analogous to that described for N-myc (Brodeur et al., 1984).
This is unlikely since neither the 4.1 kbp nor the 5.8kbp
c-ets-homologous fragments corresponds to other fragments
a h -c d a f a h i ;
23.1-
9.4 -
6.7 -
4.3 -
2.3-
Figure 1 Southern blot analysis of c-ets-l in normal and ALL
leukocyte DNAs. Peripheral blood leukocytes from normal
individuals and ALL patients were isolated, and high molecular-
weight DNA prepared, as described previously (Birnie et al., 1986).
DNA from each was incubated with Eco RI, size-fractionated
by electrophoresis through a 1% agarose gel (20Mg/lane), blotted
onto a nitrocellulose membrane, and hybridized with a human
c-ets-l probe that had been labelled with 32P by nick-translation;
the membrane was washed to 0.1 x SSC at 650 and autoradio-
graphed (Birnie et al., 1986). The c-ets-l probe was a 5.4kbp
human genomic fragment containing a sequence homologous to
the 3' end of v-ets (Leprince et al., 1983; de Taisne et al., 1984)
recloned in pKH47.
Lane (a), ALL/01; (b) ALL/02; (c) ALL/03; (d) ALL/04; (e)
ALL/05: (f) ALL/06; (g) ALL/07; (h)-(i) normal leukocytes. The
positions of phage A DNA size markers (kbp) are shown on the
left.
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in Eco RI-digested normal human DNA that hybridize
weakly with a v-ets probe (de Taisne et al., 1984). It is also
possible that aberrant-sized c-ets-1-homologous fragments are
due to naturally occurring restriction fragment length
polymorphisms. We were unable to obtain non-leukaemic
material from patients ALL/01 and ALL/04, both of whom
were children. However, we did examine the pattern ofc-ets-1
hybridization to Southern blots of Eco RI-digested DNA
from normal tissues, myeloid leukaemias, lymphomas and
cell lines, representing in total over 60 individuals, and in no
case detected any c-ets-l homologous fragment apart from
the germ-line 8.6kbp fragment (Jack et al., 1986, and data
not shown). In addition, aberrant-sized c-ets-1-homologous
fragments were found in ALL/04 DNA digested with Bgl II,
Hind III and Pvu II (Figure 2), and Cla I (data not shown),
but not in other DNAs (Figure 2). Although similar analyses
with ALL/01 DNA were not possible because of lack of
material, we conclude that the abnormal c-ets hybridization
patterns seen with Eco RI-digested DNAs from ALL/01 and
ALL/04 (Figure 1) are due to rearrangement of c-ets-I
sequences in the leukaemic cells from these patients.
Diagnoses, total leukocyte counts and karyotypes of the 7
ALL patients examined are summarized in Table I. Patients
ALL/01 and ALL/04 both exhibited high leukocyte counts
(about 200 x1091-1) at presentation; 4 of the other 5 had
leukocyte counts of less than 40 x1091-. On the basis of
morphological, cytochemical and immunological criteria,
patient ALL/O1 was diagnosed as a T-cell ALL, FAB class
LI/L2 and patient ALL/04 as a common ALL, FAB class
L2. Chromosome analysis for two patients (unfortunately
including ALL/01) was not available, and for four patients
indicated an apparently normal karyotype. Leukaemic cells
from patient ALL/04 showed a range of chromosome
deletions and the presence of several unidentifiable marker
chromosomes. The only consistent abnormality was deletion
of one chromosome 11. However, because the chromosome
morphology had the fuzzy appearance common in ALL
karyotypes, it was not possible to determine whether there
was a t(4; 11) that was masked by other translocations.
No rearrangements of c-ets-1 sequences were detected in
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Table I Clinical data of the ALL patients
Total
leukocyte count
at presentation Observed karyotypic
Patient Diagnosis (cells1-1) abnormalities
ALL/01 T-cell 210 x 109 karyotype not known
ALL/02 common 39 x 109 none
ALL/03 common 22 x 109 none
ALL/04 common 192 x 109 one chromosome 11
consistently deleted
plus unidentifiable
marker chromosomes
ALL/05 null 140 x 109 karyotype not known
ALL/06 common 21 x 109 none
ALL/07 common 12 x 109 none
Eco RI-digested leukocyte DNAs from chronic or acute-
phase chronic granulocytic leukaemias (CGLs) or ANLLs
that also had leukocyte counts greater than 200 x 1091-1 on
presentation (data not shown).
Our data constitute the first demonstration by Southern
blot analysis that rearrangements of c-ets-I sequences can
occur in ALL as well as in ANLL (Rovigatti et al., 1986).
The detection of disparate sizes of aberrant c-ets-1-
homologous fragments in Eco RI-digested DNA from the
peripheral blood leukocytes from two ALLs implies that the
position of the break-point in or near c-ets-I is variable. This
situation is similar to that documented for c-myc in Burkitt's
lymphoma (Bernard et al., 1983) and, in particular, for c-abl
in Ph1-positive CGL in which break-points on chromosome
9 from 14 to 40kbp from the v-abl-homologous sequences
have been found (Groffen et al., 1984). Thus it is possible
that we, and others, have failed to detect rearrangement of
c-ets-1 in some cases because the probe used is not capable
of detecting rearrangements involving break-points at some
distance from the c-ets-I sequence. The only factor common
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Figure 2 Southern blot analysis of c-ets-l in DNA from normal, CGL and ALL leukocytes digested with (A), Bgl II; (B) Hind
III; and (C) Pvu II. The experimental procedures were as described for Figure 1. The leukocyte DNAs were from (a), patient
ALL/04; (b) a chronic-phase CGL; (c) and (d) normal individuals; (e) patient ALL/05. The positions of phage A DNA size
markers (kbp) are shown on the left; arrows indicate the abnormal fragments in ALL/04 DNA.REARRANGEMENT OF c-ets-I IN ALL 613
to the two ALLs in whose leukocyte DNAs the rearrange-
ments of c-ets-1 sequences were found is the marked leuco-
cytosis at presentation, one noted feature of ALLs with
t(4; 1 1)(q21;q23) (Arthur et al., 1982; Rowley & Testa, 1982).
It is unforunate, therefore, that no conclusion can be drawn
from our data regarding a link between c-ets-I rearrange-
ment and a (4; 11) translocation. However, it is possible that
Southern blot analyses with c-ets-1 probes can reveal a sub-
set of patients with (4;11) translocations that are difficult to
detect in ALL karyotypes because of typically unclear
chromosome morphology and/or because they are masked
by other translocations, in a way analogous to that described
for masked Philadelphia translocations in CGL (Bartram et
al., 1985). If so, this preliminary report suggests that such
analyses could provide important diagnostic information
since ALLs with t(4; 1 l)(q21;q23) have a poor prognosis
with conventional therapy (Arthur et al., 1982; Rowley &
Testa, 1982; Mirro et al., 1986).
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